Description

This module provides an overview of topics related to club drugs and hallucinogen use, beginning with a review of the epidemiology related to the current club drug use in our country. You will then examine in detail, the pharmacology of club drugs and hallucinogens and how to identify intoxication and withdrawal in your patients.

To further expand your learning experience, you will learn how to assess your patients for club drug use. The module will round out with harm reduction and prevention techniques, treatment options and medical co-morbidities.

Module Objectives

After completing this module you will be able to:

1. Describe epidemiologic features of club drug use disorders using national U.S. data sources, including prevalence, trends, correlates and risk factors
2. Describe the pharmacokinetic properties and pharmacological actions of club drugs
3. Identify and differentiate the signs and symptoms associated with club drug withdrawal
4. Interpret the DSM-5 criteria for diagnosis of Club Drug Use Disorder and severity of symptoms and recognize how this information applies to the continuum of care for patients
5. Discuss prevention services that focus on helping patients make healthy choices or change harmful behaviors
6. Evaluate the various ways in which policies, programs and interventions have been proven to reduce the harmful effects associated with club drug use disorders
7. Recognize the various types of evidence-based screening tools, referral, and care management strategies